General Information of Drug Off-Target (DOT) (ID: OTLA4ONW)

DOT Name Eukaryotic translation initiation factor 5A-1-like (EIF5AL1)
Synonyms eIF-5A-1-like; eIF-5A1-like; Eukaryotic initiation factor 5A isoform 1-like
Gene Name EIF5AL1
Related Disease
Malaria ( )
Colorectal carcinoma ( )
Epithelial ovarian cancer ( )
Lung adenocarcinoma ( )
Neoplasm ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Qualitative or quantitative defects of dysferlin ( )
UniProt ID
IF5AL_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF01287 ; PF21485
Sequence
MADDLDFETGDAGASATFPMQCSALRKNGFVVLKGWPCKIVEMSASKTGKHGHAKVHLVG
IDIFTGKKYEDICPSTHNMDVPNIKRNDFQLIGIQDGYLSLLQDSGEVPEDLRLPEGDLG
KEIEQKYDCGEEILITVLSAMTEEAAVAIKAMAK
Function
Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts. Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome. Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step. Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity.

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Malaria DISQ9Y50 Definitive Biomarker [1]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [2]
Epithelial ovarian cancer DIS56MH2 Strong Biomarker [3]
Lung adenocarcinoma DISD51WR Strong Biomarker [4]
Neoplasm DISZKGEW Strong Altered Expression [4]
Ovarian cancer DISZJHAP Strong Biomarker [3]
Ovarian neoplasm DISEAFTY Strong Biomarker [3]
Qualitative or quantitative defects of dysferlin DIS59VEJ Strong Biomarker [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Eukaryotic translation initiation factor 5A-1-like (EIF5AL1). [6]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Eukaryotic translation initiation factor 5A-1-like (EIF5AL1). [9]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Eukaryotic translation initiation factor 5A-1-like (EIF5AL1). [7]
Diethylstilbestrol DMN3UXQ Approved Diethylstilbestrol increases the expression of Eukaryotic translation initiation factor 5A-1-like (EIF5AL1). [8]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Eukaryotic translation initiation factor 5A-1-like (EIF5AL1). [10]
------------------------------------------------------------------------------------

References

1 Deoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileuton.PLoS One. 2013;8(3):e58318. doi: 10.1371/journal.pone.0058318. Epub 2013 Mar 7.
2 Integrative analysis of significant RNA-binding proteins in colorectal cancer metastasis.J Cell Biochem. 2018 Dec;119(12):9730-9741. doi: 10.1002/jcb.27290. Epub 2018 Aug 21.
3 Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer.Cancer Res. 2001 May 1;61(9):3806-9.
4 Proteomic analysis of eIF-5A in lung adenocarcinomas.Proteomics. 2003 Apr;3(4):496-504. doi: 10.1002/pmic.200390063.
5 Proteomic analysis of the skeletal muscles from dysferlinopathy patients.J Clin Neurosci. 2020 Jan;71:186-190. doi: 10.1016/j.jocn.2019.08.068. Epub 2019 Aug 19.
6 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
7 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
8 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.